Cochlear posts record revenue for 1H15
10 February, 2015 by Dylan Bushell-EmblingCochlear (ASX:COH) has reported a 240% surge in profit and 18% increase in revenue for the first half of FY15.
AusBiotech submissions say employee share scheme eligibility too tight
10 February, 2015Two AusBiotech submissions have asked the federal government to broaden the eligibility criteria for employee share schemes (ESSs) to allow extra benefits planned for start-up companies to extend to listed companies eligible for the refundable Research and Development (R&D) Tax Incentive.
Orthocell expands into HK with Ortho-ATI
09 February, 2015 by Dylan Bushell-EmblingOrthocell (ASX:OCC) has announced that the first two Hong Kong patients have been treated with its Ortho-ATI tendon repair therapy product.
Nanosonics to build direct sales team in NA
06 February, 2015 by Dylan Bushell-EmblingNanosonics (ASX:NAN) plans to build up a team to conduct direct sales operations in the US and Canada for its ultrasound probe disinfection product trophon EPR.
Delegations set to support global outreach of Australian biotech and medtech
05 February, 2015AusBiotech will be leading missions to the world's largest and most relevant biotech and medtech events over the coming months - in Shanghai, Hong Kong, Korea and USA - to support Australian companies in their outreach and global development.
Invion completes enrolment in INV102 trial
05 February, 2015 by Dylan Bushell-EmblingInvion (ASX:IVX) has completed recruitment in a trial of INV102 in smoking cessation for chronic bronchitis patients, shortly after announcing positive interim results.
Call for AusBiotech 2015 session proposals
04 February, 2015AusBiotech is inviting session proposals for life science conference AusBiotech 2015. This is your opportunity to have a say and lead discussions, bringing new and diverse topics to the forefront of the life sciences industry.
Biofuel from rice
04 February, 2015A simple farm-based method for producing biofuels and feed for animals.
Annual industry position survey seeking CEOs' views
03 February, 2015AusBiotech calls on leaders of biotechnology companies (CEOs and MDs) to respond to the annual Biotechnology Industry Position Survey 2015, enabling them to contribute to the annual snapshot and build the advocacy platform for the year to come.
Orthocell picks up US patent for Celgro
03 February, 2015 by Dylan Bushell-EmblingOrthocell (ASX:OCC) has been awarded a US patent covering the use of its Celgro collagen bio-scaffold in soft tissue reconstruction applications.
Bionomics initiates phase Ib trial of anxiety drug
03 February, 2015 by Dylan Bushell-EmblingBionomics (ASX:BNO) has commenced a phase Ib trial of BNC210, its anxiety and depression drug candidate, and is laying the groundwork for a phase IIa trial due to begin this quarter.
Avita enrols first patient for key burns trial
30 January, 2015 by Dylan Bushell-EmblingAvita Medical (ASX:AVH) has started recruiting for a phase III trial of ReCell in burn injuries, as part of its application process in the US and by extension the UK.
ResMed boosts December quarter profit by 5%
29 January, 2015 by Dylan Bushell-EmblingSleep-disordered breathing technology company ResMed (ASX:RMD) has reported a 5% increase in profit and a 10% hike in revenue for the December quarter.
Foresight to translate research into treatments, devices and diagnostics
29 January, 2015Amid the growing realisation that Australian research needs support to make it a reality, the Queensland Premier has pledged a "centrepiece" $90 million Research to Reality Fund if the LNP is returned in this weekend's election.
Highlighting the digital health achievements of the sector
27 January, 2015Digital health is one of the strongest trends in healthcare and is transforming the delivery of healthcare around the world, including, but not limited to, digital applications (apps) and wearable technology. AusBiotech members are increasingly developing digital health technologies.
